- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 16.66M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $22.06M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $41.59M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $28.21M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $19.93M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $19.07M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $12.29M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $14.82M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $12.29M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $14.82M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $54.91M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $64.44M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $56.42M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $66.91M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 42.58M sh |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$7.98M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $83.37M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $88.74M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.15 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.15 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $3.71M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$6.25M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$7.38M |
| Revenue | Q1 2025 · Mar 31, 2024 | $98K |